Galmed Pharmaceuticals Ltd.
Related Filers (7)
- Baharaff Allen (10)
- BIOTECHNOLOGY VALUE FUND L P (6)
- Hurvitz Chaim (4)
- 683 Capital Management, LLC (3)
- Ibex Investors LLC (3)
- Nantahala Capital Management, LLC (2)
- CVI Investments, Inc. (2)
- Show More ...
Other (206)
EFFECT
Wednesday, 11/29/2023
Notice of Effectiveness
6-K
Wednesday, 11/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
POS AM
Wednesday, 11/22/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Monday, 11/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
POS AM
Wednesday, 11/1/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Tuesday, 9/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Thursday, 9/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 7/14/2023
Notice of Effectiveness
F-1/A
Thursday, 7/13/2023
Registration statement for securities of certain foreign private issuers
F-1/A
Wednesday, 7/12/2023
Registration statement for securities of certain foreign private issuers
CORRESP
Wednesday, 7/12/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 7/12/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 7/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-1/A
Wednesday, 6/28/2023
Registration statement for securities of certain foreign private issuers
F-1
Friday, 6/16/2023
Registration statement for securities of certain foreign private issuers
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 3/29/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 2/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Monday, 5/2/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 4/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/8/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/1/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/12/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/31/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/23/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/19/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/2/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/19/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/2/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Thursday, 4/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 4/1/2021
Notice of Effectiveness
F-3
Friday, 3/26/2021
Registration statement for specified transactions by certain foreign private issuers
6-K
Friday, 3/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/18/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/18/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 3/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/18/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/17/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/12/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/9/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/9/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/8/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/19/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/21/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/18/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/15/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/12/2020
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/12/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/6/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/31/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/5/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/13/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/7/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/9/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/4/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 3/13/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 3/13/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/12/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/26/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/14/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (30)
SC 13G/A
Wednesday, 2/14/2024
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CVI Investments, Inc.: Major Shareholders
SC 13G/A
Monday, 2/12/2024
Baharaff Allen: Major Shareholders
SC 13G
Friday, 7/21/2023
CVI Investments, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Tuesday, 2/7/2023
Baharaff Allen: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Nantahala Capital Management, LLC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Baharaff Allen: Major Shareholders
SC 13G/A
Thursday, 1/27/2022
Ibex Investors LLC: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Nantahala Capital Management, LLC: Major Shareholders
SC 13G/A
Friday, 2/12/2021
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Baharaff Allen: Major Shareholders
SC 13G/A
Friday, 1/15/2021
Ibex Investors LLC: Major Shareholders
SC 13G
Tuesday, 7/28/2020
Ibex Investors LLC: Major Shareholders
SC 13G/A
Friday, 2/14/2020
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Thursday, 2/13/2020
Baharaff Allen: Major Shareholders
SC 13G/A
Thursday, 2/13/2020
683 Capital Management, LLC: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
Hurvitz Chaim: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Monday, 2/11/2019
Baharaff Allen: Major Shareholders
SC 13G/A
Friday, 6/22/2018
683 Capital Management, LLC: Major Shareholders
SC 13G
Monday, 4/16/2018
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 1/26/2018
Hurvitz Chaim: Major Shareholders
SC 13G/A
Friday, 1/26/2018
Baharaff Allen: Major Shareholders
SC 13G
Monday, 12/18/2017
683 Capital Management, LLC: Major Shareholders
SC 13G/A
Monday, 2/13/2017
Baharaff Allen: Major Shareholders
SC 13G/A
Monday, 2/13/2017
Hurvitz Chaim: Major Shareholders
SC 13G/A
Tuesday, 2/16/2016
Baharaff Allen: Major Shareholders
SC 13G
Tuesday, 1/13/2015
Hurvitz Chaim: Major Shareholders
SC 13G
Tuesday, 1/13/2015
Baharaff Allen: Major Shareholders
Prospectus (20)
424B4
Tuesday, 7/18/2023
Prospectus filed pursuant to Rule 424(b)(4)
FWP
Wednesday, 6/28/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Friday, 7/1/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 2/18/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 2/16/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 5/15/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8 POS
Monday, 10/29/2018
Post-effective amendment to a S-8 registration statement
S-8
Thursday, 9/20/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Thursday, 6/21/2018
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Monday, 6/18/2018
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Monday, 6/18/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 4/4/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 12/22/2017
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 8/7/2017
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 6/1/2016
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Tuesday, 8/11/2015
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 3/13/2014
Prospectus filed pursuant to Rule 424(b)(4)
424A
Monday, 3/3/2014
Prospectus filed pursuant to Rule 424(a)
DRSLTR
Thursday, 2/6/2014
Correspondence Related to Draft Registration Statement
DRS
Tuesday, 12/31/2013
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy